ABL1 and acute lymphoblastic leukemia: As the biological consequences of TEL/ABL are similar to those of BCR/ABL [25,26,27], the effects of targeted down-regulation of BCR in these cells should allow to estimate the contribution of BCR down-regulation to the effects of targeting p96ABL/BCR in Ph+ ALL cells.